What is the management of cholesteatoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Cholesteatoma

Surgical excision is the only effective treatment for cholesteatoma, as there are no viable nonsurgical therapies currently available. 1, 2, 3

Immediate Referral and Diagnosis

Any patient with suspected cholesteatoma must be referred immediately to an otolaryngologist for definitive surgical management. 4, 5 The diagnosis should be suspected in patients presenting with:

  • Painless, foul-smelling purulent otorrhea (most common presentation) 5
  • Hearing loss, tinnitus, and ear fullness 5
  • Tympanic membrane abnormalities including retraction pockets, perforation, white keratinous debris visible behind intact membrane, or granulation tissue 4, 5
  • Attic blockage and scutum erosion on careful otoscopic examination 5

Preoperative Imaging Strategy

High-resolution CT temporal bone without IV contrast is the cornerstone imaging modality for presurgical planning, providing excellent anatomic detail of bony structures and determining disease extent. 4 This imaging:

  • Accurately detects ossicular erosion, scutum erosion, tegmen erosion, and lateral semicircular canal erosion 4
  • Identifies potential surgical hazards and guides surgical approach decisions 4
  • Should NOT be ordered with IV contrast, as it provides no additional necessary bony detail 4

MRI with non-echoplanar diffusion-weighted imaging (DWI) in the coronal plane is essential for differentiating cholesteatoma from other soft tissue pathology, including scar tissue and inflamed granulation tissue, with high sensitivity and specificity. 4

Surgical Approach Selection

The surgical technique should be tailored to the extent and location of disease:

For Limited Disease (Type 1)

  • Retraction of Shrapnell's membrane or posterosuperior quadrant with minimal cholesteatoma lateral to ossicles: Transcanal technique to evert the cholesteatomatous pocket intact, followed by reconstruction of the outer attic wall 6
  • Atticotomy/limited mastoidectomy (inside-outside approach through endaural incision) creates small, dry, self-cleaning cavities without need for meatoplasty or obliteration 7

For Moderate Disease (Type 2)

  • Circumscribed cholesteatoma lateral and often medial to ossicles: Combined approach tympanoplasty or canal wall up mastoidectomy 6
  • If luxation of matrix in toto fails, proceed to radical mastoidectomy 6

For Extensive Disease (Type 3)

  • Marginal perforations with large cholesteatomas medial to ossicular chain: Canal wall down mastoidectomy is the method of choice 8, 6
  • Extensive cholesteatomas with tegmen erosion, sigmoid sinus invasion, or jugular bulb involvement: Canal wall down mastoidectomy with or without ossiculoplasty, with neurosurgical intervention considered in the same sitting when intracranial complications present 8

Critical Surgical Considerations

The choice of operative procedure must account for disease extent and surgeon experience, with the primary goal being complete disease eradication while minimizing recurrence risk. 7, 6 Key anatomical hazards to anticipate include:

  • Ossicular chain erosion (most common) 4
  • Facial canal dehiscence 1
  • Lateral semicircular canal erosion 4, 1
  • Tegmen tympani or tegmen mastoideum erosion with potential brain hernia or CSF leak 8
  • Sigmoid sinus or jugular bulb invasion in extensive cases 8

Postoperative Management

Intravenous antibiotics are required postoperatively, with consideration of IV steroids when indicated. 8 The polymicrobial bacterial flora typically includes H. influenzae, S. aureus, and P. aeruginosa. 5, 1

Postoperative Surveillance

CT temporal bone without IV contrast is the primary modality for detecting recurrent cholesteatoma, evaluating for abnormal, new, or enlarging lobulated material in the temporal bone region. 4

MRI with DWI and delayed postcontrast T1-weighted imaging differentiates recurrent cholesteatoma from postoperative granulation tissue and scar, which is critical for distinguishing keratinous debris from non-cholesteatoma findings postoperatively. 4

Common Pitfalls to Avoid

  • Never rely on plain radiography, as it has no role in cholesteatoma diagnosis or surveillance 4
  • Do not confuse cholesteatoma with simple acute otitis media or ventilation tube-associated otorrhea, as cholesteatoma requires surgical management and is characterized by white keratinous debris 5
  • Avoid CT with IV contrast, as it provides no additional necessary information 4
  • Do not delay referral to otolaryngology, as untreated cholesteatoma causes progressive bone erosion through enzymatic activity and pressure effects, leading to potentially fatal intracranial complications 1, 3

References

Guideline

Cholesteatoma Pathogenesis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Updates and knowledge gaps in cholesteatoma research.

BioMed research international, 2015

Guideline

Cholesteatoma Imaging and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cholesteatoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Some considerations on middle ear cholesteatoma in 'foreign workers'.

Clinical otolaryngology and allied sciences, 1978

Research

Extensive Cholesteatomas: Presentation, Complications and Management Strategy.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.